Markets

Insider Trading

Hedge Funds

Retirement

Opinion

5 Best Cheap Dividend Stocks To Buy Now

In this article, we discuss 5 best cheap dividend stocks to buy now. If you want to read our detailed analysis of dividend stocks and their performance, go directly to read 12 Best Cheap Dividend Stocks To Buy Now

5. QUALCOMM Incorporated (NASDAQ:QCOM)

Number of Hedge Fund Holders: 73
P/E Ratio as of August 20: 11.74

QUALCOMM Incorporated (NASDAQ:QCOM) is an American multinational tech company that is mainly known for its contributions to the development of wireless communication technologies and mobile computing. On July 14, the company declared a quarterly dividend of $0.80 per share, which was in line with its previous dividend. The stock offers a dividend yield of 2.91%, as of August 20.

The number of hedge funds tracked by Insider Monkey owning stakes in QUALCOMM Incorporated (NASDAQ:QCOM) jumped to 73 in Q2 2023, from 69 in the previous quarter. The total value of these stakes is over $2.3 billion.

Follow Qualcomm Inc (NASDAQ:QCOM)

4. Pfizer Inc. (NYSE:PFE)

Number of Hedge Fund Holders: 73
P/E Ratio as of August 20: 7.23

Pfizer Inc. (NYSE:PFE) is an American multinational pharmaceutical and biotech company. It currently pays a quarterly dividend of $0.41 per share and has a dividend yield of 4.47%, as of August 20. The company has been growing its dividends consistently for the past 13 years, which makes it one of the best dividend stocks on our list. As of August 20, the stock has a dividend yield of 4.47%.

As of the close of Q2 2023, 73 hedge funds in Insider Monkey’s database reported having stakes in Pfizer Inc. (NYSE:PFE), the same as in the previous quarter. The consolidated value of these stakes is over $1.5 billion. Citadel Investment Group was the company’s leading stakeholder in Q2.

Follow Pfizer Inc (NYSE:PFE)

3. Chevron Corporation (NYSE:CVX)

Number of Hedge Fund Holders: 73
P/E Ratio as of August 20: 8.69

An American energy company, Chevron Corporation (NYSE:CVX) is next on our list of the best dividend stocks to consider now. The company has been raising its dividends consistently for the past 36 years and offers a quarterly dividend of $1.51 per share. The stock has a dividend yield of 3.77%, as of August 20.

Chevron Corporation (NYSE:CVX) was a popular stock among hedge funds in Q2 2023, as hedge fund positions in the company grew to 73 during the quarter, from 64 a quarter earlier, as per Insider Monkey’s database. The collective value of stakes owned by these money managers is over $21.4 billion.

Follow Chevron Corp (NYSE:CVX)

2. Elevance Health, Inc. (NYSE:ELV)

Number of Hedge Fund Holders: 82
P/E Ratio as of August 20: 17.24

Elevance Health, Inc. (NYSE:ELV) is an American health insurance company, previously known as Anthem. It currently pays a quarterly dividend of $1.48 per share and the stock has a dividend yield of 1.33%, as recorded on August 20. During its second quarter of 2022, the company distributed $350 million to shareholders through dividends, which makes it one of the best dividend stocks on our list.

At the end of the June quarter of 2023, 82 hedge funds in Insider Monkey’s database reported having stakes in Elevance Health, Inc. (NYSE:ELV), up from 81 in the preceding quarter. Their collective stake value is over $5.33 billion.

Madison Investments mentioned Elevance Health, Inc. (NYSE:ELV) in its Q2 2023 investor letter. Here is what the firm has to say:

“We purchased Elevance Health, Inc. (NYSE:ELV) and trimmed Marsh & McLennan and Arch Capital. Elevance is the largest for-profit Blue Cross Blue Shield plan in the country, supporting the largest domestic membership base across the managed care industry. While national scale is important, local scale is critical as well, given the localized nature of healthcare delivery. Elevance scores well on both fronts, giving it strong bargaining power with providers, lower customer acquisition costs, deep population health data and analytics, and the ability to offer attractive health benefit packages. All this combines to create a formidable moat for its business.

We also believe the management team is top-notch. Since joining Elevance from a senior leadership position at peer UnitedHealth Group, CEO Gail Boudreaux has further leveraged the company’s scale advantage by expanding its internal healthcare services capabilities through a newly formed business unit called Carelon. As the industry transitions to a reimbursement system that emphasizes patient outcomes over procedure or testing volume, data analytics will be a crucial tool in managing patient care. Carelon has become the repository for many of these data analytics and healthcare service capabilities, and it should be an attractive growth platform for many years to come. Concerns around a possible slowdown in government-sponsored programs in Medicare Advantage and managed Medicaid gave us an opportunity to invest at a good price.”

Follow Elevance Health Inc. (NYSE:ELV)

1. JPMorgan Chase & Co. (NYSE:JPM)

Number of Hedge Fund Holders: 106
P/E Ratio as of August 20: 9.57

JPMorgan Chase & Co. (NYSE:JPM) tops our list of the best dividend stocks to consider now. The company pays a quarterly dividend of $1 per share and has a dividend yield of 2.73%, as of August 20.

At the end of Q2 2023, 106 hedge funds tracked by Insider Monkey owned positions in JPMorgan Chase & Co. (NYSE:JPM), worth collectively over $4.38 billion.

Madison Investments mentioned JPMorgan Chase & Co. (NYSE:JPM) in its Q2 2023 investor letter. Here is what the firm has to say:

“JPMorgan Chase & Co. (NYSE:JPM) has rebounded nicely following the mini-bank crisis in March. They held an analyst meeting in May at which they gave updated guidance on net interest income. They expect net interest income to increase to $84 billion from its forecast of $81 billion as First Republic assets will get a nice boost from rising interest rates.”

Follow Jpmorgan Chase & Co (NYSE:JPM)

You can also take a look at Ken Fisher’s Top 15 Energy Stock Picks and 10 Best Dividend Stocks Yielding at Least 7% According to Hedge Funds

Follow Insider Monkey on Twitter

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.